HIV/AIDS
Studies from Italy and the United States advance knowledge in HIV/AIDS research
Published in Drug Week, June 16th, 2006
Study 1: Coreceptor-targeted HIV entry inhibitors will bridge the gap towards a cure for HIV infection.
According to a recent review from Italy, "The unexpected encounter, 10 years ago, between human immunodeficiency virus (HIV) and the chemokine system has dramatically advanced our understanding of the pathogenesis of AIDS, opening new perspectives for the development of effective prophylactic and therapeutic measures."
"To initiate infection, the HIV-1 external envelope glycoprotein, gp120, sequentially interacts with two cellular receptors, CD4 and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2006-06-16)
More Articles from Drug Week
- Cardiology
Acadesine reduces 2-year mortality following heart attacks in heart bypass patients - Drug Development
Acologix presents preclinical data on synthetic peptide - Drug Development
Axonyx completes multiple-dose phase I study of Posiphen - HIV/AIDS Drug Development
HIV-1 CD4 attachment inhibitor inhibits viral entry by altering envelope conformation - Sexual & Reproductive Health
ImQuest: Pyrimidinedione appears to prevent HIV transmission - Addiction Medicine
Bivalent morphine/heroin vaccine prevents relapse to heroin addiction - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
